Literature DB >> 2579900

Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors.

L Hammarström, M A Persson, C I Smith.   

Abstract

The IgG and IgA subclass distribution of anti-carbohydrate antibodies in normal and immunodeficient donors was investigated. In normal donors, the specific anti-dextran antibodies were mainly of the IgG2 and IgA2 subclass, although substantial amounts of antibodies could also be of the IgG1 subclass. In children, IgG1 was the predominant subclass expressed. An aberrant IgG subclass distribution pattern of specific antibodies occurred in some IgA-deficient donors, with preferential expression of IgG1 and IgG3 anti-dextran antibodies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579900      PMCID: PMC1453556     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Light chain isotypes selectively associate with heavy chain idiotypes in T-dependent and T-independent dextran-specific precursors.

Authors:  R E Ward; J F Kearney; H Köhler
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

Review 2.  Functional aspects of IgM and IgG Fc receptors on murine T lymphocytes.

Authors:  B Andersson; A C Skoglund; M Rönnholm; T Lindsten; E W Lamon; E W Collisson; A S Walia
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

Review 3.  Human IgG subclasses in health and disease. (A review). Part II.

Authors:  F Shakib; D R Stanworth
Journal:  Ric Clin Lab       Date:  1980 Oct-Dec

4.  Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children.

Authors:  A Freijd; L Hammarström; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

6.  The primary immune response in patients with selective IgA deficiency.

Authors:  P A De Graeff; T H The; P J van Munster; T A Out; J M Vossen; B J Zegers
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay.

Authors:  I J Seppälä; N Routonen; A Sarnesto; P A Mattila; O Mäkelä
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

8.  Subclass distribution of human anti-Staphylococcus aureus alpha toxin antibodies: suggestion of an IgG1, IgA1, IgG4 switch pattern.

Authors:  L Hammarström; M A Persson; C I Smith
Journal:  Scand J Immunol       Date:  1984-09       Impact factor: 3.487

9.  IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency.

Authors:  V A Oxelius; A B Laurell; B Lindquist; H Golebiowska; U Axelsson; J Björkander; L A Hanson
Journal:  N Engl J Med       Date:  1981-06-11       Impact factor: 91.245

10.  Dextran-reactive antibodies in children. Appearance during the first 4 years of life and relation to E. coli infections in the urinary tract.

Authors:  G Hattevig; B Kjellman; A W Richter; B Björkstén
Journal:  Acta Paediatr Scand       Date:  1983-11
View more
  13 in total

1.  An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system.

Authors:  D E Mosedale; D J Grainger
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.

Authors:  B Simell; T Kilpi; H Käyhty
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

4.  IgG subclass-containing cells in the human large bowel of normal controls, non-IBD colitis, and ulcerative colitis.

Authors:  M Iizuka
Journal:  Gastroenterol Jpn       Date:  1990-02

5.  Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.

Authors:  C Peeters; A M Tenbergen-Meekes; J Poolmann; B Zegers; G Rijkers
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

6.  IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.

Authors:  T Pressler; S S Pedersen; F Espersen; N Høiby; C Koch
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion.

Authors:  Qiaozhen Lu; Vered Padler-Karavani; Hai Yu; Xi Chen; Shiaw-Lin Wu; Ajit Varki; William S Hancock
Journal:  Anal Chem       Date:  2012-02-28       Impact factor: 6.986

8.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

9.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

10.  Development of anti-polysaccharide antibodies in asplenic children.

Authors:  L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.